Research / XYL / Fundamental state Inspectable configuration
State dimensions Filing 0001524472-26-000012 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
21.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.66% · OPTIONAL · VALID
Operating cash generation 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
13.74% · OPTIONAL · VALID
Revenue growth 30th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
5.52% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
10.88% · OPTIONAL · VALID
Gross margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
38.46% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
13.54% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.50% · OPTIONAL · VALID
SBC intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.59% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 49 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 8/9 normalized Level 3 Mar 31, 2026 8/9 normalized Level 3 Jun 30, 2026 8/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 87.08%
Current 21.63%
Delta -65.45% Capex Intensity Increased
Previous 3.48%
Current 3.66%
Delta 0.18% Cash Generation Decreased
Previous 15.87%
Current 13.74%
Delta -2.14% Growth Decreased
Previous 7.79%
Current 5.52%
Delta -2.27% Inventory Pressure Decreased
Previous 45.63%
Current 10.88%
Delta -34.76% Margin Decreased
Previous 38.93%
Current 38.46%
Delta -0.47% Profitability Decreased
Previous 14.73%
Current 13.54%
Delta -1.19% R And D Intensity Increased
Previous 2.29%
Current 2.50%
Delta 0.21% Sbc Intensity Increased
Previous 0.53%
Current 0.59%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.